Literature DB >> 15383668

Role for PP2A in ARF signaling to p53.

Madeleine G Moule1, Crista H Collins, Frank McCormick, Mike Fried.   

Abstract

Activation of the ARF-p53 tumor suppressor pathway is one of the cell's major defense mechanisms against cancer induced by oncogenes. The ARF-p53 pathway is dysfunctional in a high proportion of human cancers. The regulation of the ARF-p53 signaling pathway has not yet been well characterized. In this study polyoma virus (Py) is used as a tool to better define the ARF-p53 signaling pathway. Py middle T-antigen (PyMT) induces ARF, which consequently up-regulates p53. We show that Py small T-antigen (PyST) blocks ARF-mediated activation of p53. This inhibition requires the small T-antigen PP2A-interacting domain. Our results reveal a previously unrecognized role of PP2A in the modulation of the ARF-p53 tumor suppressor pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383668      PMCID: PMC521121          DOI: 10.1073/pnas.0405533101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Protein phosphatase 2A: the Trojan Horse of cellular signaling.

Authors:  E Sontag
Journal:  Cell Signal       Date:  2001-01       Impact factor: 4.315

Review 2.  The ARF/p53 pathway.

Authors:  C J Sherr; J D Weber
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

Review 3.  Regulation of p53 function.

Authors:  D B Woods; K H Vousden
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 4.  Type 2A protein phosphatase, the complex regulator of numerous signaling pathways.

Authors:  S Zolnierowicz
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

5.  The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.

Authors:  L A Allan; T Duhig; M Read; M Fried
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  ARF function does not require p53 stabilization or Mdm2 relocalization.

Authors:  Chandrashekhar Korgaonkar; Lili Zhao; Modestos Modestou; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Polyoma virus disrupts ARF signaling to p53.

Authors:  M Lomax; M Fried
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

8.  Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.

Authors:  S Llanos; P A Clark; J Rowe; G Peters
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

Review 9.  The INK4a/ARF network in tumour suppression.

Authors:  C J Sherr
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 10.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

View more
  16 in total

1.  Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function.

Authors:  Shaida Andrabi; Justin H Hwang; Jennifer Kean Choe; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control.

Authors:  Pablo Rodriguez-Viciana; Crista Collins; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

3.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

4.  p53 targets identified by protein expression profiling.

Authors:  Rubaiyat Rahman-Roblick; Uwe Johannes Roblick; Ulf Hellman; Paolo Conrotto; Tao Liu; Susanne Becker; Daniel Hirschberg; Hans Jörnvall; Gert Auer; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

Review 5.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  Expression of the small T antigen of Lymphotropic Papovavirus is sufficient to transform primary mouse embryo fibroblasts.

Authors:  Tushar Gupta; Maria Teresa Sáenz Robles; Rachel M Schowalter; Christopher B Buck; James M Pipas
Journal:  Virology       Date:  2015-10-27       Impact factor: 3.616

7.  Human cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancer incidence in Aα knock-in and knockout mice.

Authors:  Ralf Ruediger; Jennifer Ruiz; Gernot Walter
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

8.  Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.

Authors:  Toshiyuki Amano; Akira Nakamizo; Sandip K Mishra; Joy Gumin; Naoki Shinojima; Raymond Sawaya; Frederick F Lang
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 9.  Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation.

Authors:  Kamel Khalili; Ilker Kudret Sariyer; Mahmut Safak
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

Review 10.  Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

Authors:  Pradip De; Jennifer H Carlson; Brian Leyland-Jones; Nandini Dey
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.